MedPath

Alcohol addiction: treatment with omega-3 to prevent alcohol use

Phase 3
Terminated
Conditions
Binge drinking
C25.775.100
Registration Number
RBR-48mkgz7
Lead Sponsor
niversidade Federal de São Paulo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Terminated
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

Male; age between 18 and 70 years; severe alcohol use disorder according to DSM-5 criteria (Diagnostic and Statistical Manual of Mental Disorders 5th. edition)

Exclusion Criteria

Volunteers with a history of allergic processes to fish; severe pathological history of hepatic, cardiovascular, renal, pulmonary, endocrine, neurological and psychiatric disorders with psychotic symptoms such as schizophrenia

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Expected outcome 1: To verify the possible reduction in the number and intensity of relapses in alcohol-dependent patients who received omega during 3 months of hospitalization, using the Timeline Followback questionnaire, pre-intervention and post-intervention.;Outcome found 1: the group that received omega consumed alcohol in fewer days, compared to the control group, in the evaluation of two months after the start of treatment and three months after the start of treatment, using the Timeline Followback questionnaire, comparing the baseline measurement (pre-intervention) with the measurement after 1, 2 and 3 months of treatment.
Secondary Outcome Measures
NameTimeMethod
Anxiety symptoms were evaluated based on the score obtained by completing the Beck Anxiety Inventory questionnaire, comparing the pre-intervention and post-intervention scores. No statistically significant differences were found.;Symptoms of depression were evaluated based on the score obtained by completing the Beck Depression Inventory questionnaire, comparing the pre-intervention and post-intervention scores. No statistically significant differences were found.
© Copyright 2025. All Rights Reserved by MedPath